Lumida
/TERN
⌘K
Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc

TERN
$52.95USD+0.04%+0.02 today

MARKET CAP

6.1B

P/E (TTM)

FWD P/E

DAY RANGE

$53 – $53

52W RANGE

$3
$53

AI Summary

Stalk
StalkMedium

TERN is in a clear Stage 2 advancing regime with a dominant higher highs & higher lows pattern and rising EMAs, but price is currently extended above structure and extreme overbought—medium-term bias remains bullish, yet short-term timing is neutral; wait for a pullback into the rising EMA zone before initiating longs.

  • Merck’s $6.7B all-cash deal at $53.00/share reflects strong premium
  • Deal closed May 5, 2026, minimizing acquisition uncertainty
  • Post-acquisition delisting halts TERN trading, stripping liquidity
Full analysis →
Insider Trades22 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Apr 1, 2026SellTERNEmil KuriakoseChief Medical Officer942$52.75$6.1B-0.45%+1894.35%$49.7K-0.88%Stalk
Mar 16, 2026SellTERNAmy L. BurroughsChief Executive Officer29,166$25.67$6.1B-0.45%+1894.35%$748.8K+0.00%10b5-1Stalk
Feb 17, 2026SellTERNAmy L. BurroughsChief Executive Officer29,166$21.92$6.1B-0.45%+1894.35%$639.2K+0.00%10b5-1Stalk
Jan 15, 2026SellTERNAmy L. BurroughsChief Executive Officer137,498$20.86$6.1B-0.45%+1894.35%$2.9M+0.00%10b5-1Stalk
Jan 2, 2026SellTERNEmil KuriakoseChief Medical Officer1,155$38.57$6.1B-0.45%+1894.35%$44.6K-1.12%Stalk
Jan 2, 2026SellTERNAmy L. BurroughsChief Executive Officer92,890$30.34$6.1B-0.45%+1894.35%$2.8M-3.82%Stalk
Oct 1, 2025SellTERNEmil KuriakoseChief Medical Officer944$7.85$6.1B-0.45%+1894.35%$7.4K-1.80%Stalk
Jul 1, 2025SellTERNEmil KuriakoseChief Medical Officer853$4.27$6.1B-0.45%+1894.35%$3.6K-1.60%Stalk
Jun 27, 2025BuyTERNAndrew GengosChief Financial Officer10,000$3.93$6.1B-0.45%+1894.35%$39.3K+28.57%Stalk
Jun 25, 2025BuyTERNAmy L. BurroughsChief Executive Officer23,314$3.87$6.1B-0.45%+1894.35%$90.2K+98.09%Stalk
Jun 13, 2025BuyTERNAndrew GengosChief Financial Officer15,000$3.81$6.1B-0.45%+1894.35%$57.1K+100.00%Stalk
Apr 1, 2025SellTERNEmil KuriakoseChief Medical Officer952$2.49$6.1B-0.45%+1894.35%$2.4K-1.75%Stalk
Jan 2, 2025SellTERNEmil KuriakoseChief Medical Officer4,481$5.71$6.1B-0.45%+1894.35%$25.6K-7.63%Stalk
Jan 2, 2025SellTERNMark J. VignolaChief Financial Officer17,188$5.76$6.1B-0.45%+1894.35%$99.0K-9.78%10b5-1Stalk
Dec 5, 2024BuyTERNAmy L. BurroughsChief Executive Officer15,450$7.15$6.1B-0.45%+1894.35%$110.5K+423.40%Stalk
Nov 30, 2024BuyTERNAmy L. BurroughsChief Executive Officer510$5.11$6.1B-0.45%+1894.35%$2.6K+0.05%Stalk
Nov 30, 2024BuyTERNMelita Sun JungChief Business Officer2,250$5.11$6.1B-0.45%+1894.35%$11.5K+0.69%Stalk
Sep 10, 2024SellTERNMark J. VignolaChief Financial Officer20,000$8.18$6.1B-0.45%+1894.35%$163.6K+0.00%10b5-1Stalk
May 31, 2024BuyTERNMark J. VignolaChief Financial Officer4,791$4.44$6.1B-0.45%+1894.35%$21.3K+5.50%Stalk
May 31, 2024BuyTERNSeokho Bryan YoonCOO and General Counsel4,791$4.44$6.1B-0.45%+1894.35%$21.3K+5.50%Stalk
Nov 30, 2023BuyTERNMark J. VignolaChief Financial Officer743$3.78$6.1B-0.45%+1894.35%$2.8K+4.21%Stalk
Nov 30, 2023BuyTERNSeokho Bryan YoonCOO and General Counsel743$3.78$6.1B-0.45%+1894.35%$2.8K+4.21%Stalk